Exane Derivatives’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-173	Closed	-$2.06K	–	675
2020 Q1	$2.06K	Hold	173	–	–	﹤0.01%	475
2019 Q4	$2.19K	Sell	173 -4,780	-97%	-$60.5K	﹤0.01%	468
2019 Q3	$70K	Hold	4,953	–	–	0.01%	335
2019 Q2	$55.2K	Buy	+4,953	New	+$55.2K	0.01%	367